Low-dose megestrol strengthens hormone therapy in ER-positive breast cancer

Breast cancer: Hot flash drug slows tumor growth even at low doses

Megestrol, which helps treat hot flashes associated with menopause, may have the added benefit of slowing the growth of ER-positive breast tumors, a new trial has found.

Low-dose megestrol strengthens hormone therapy in ER-positive breast cancer

Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving treatment adherence in the PIONEER trial.

Megestrol Acetate’s Role in Early-Stage ER-Positive Breast Cancer

Explaining megestrol acetate's dual role in managing symptoms and enhancing treatment efficacy for estrogen receptor-positive breast cancer.